Recent and anticipated novel drug approvals for 2023 and 2024

CONCLUSION: Cellular and gene therapies continue to strengthen the pipeline as potential new treatment options for genetic disorders, rare diseases, and cancer. Additional diseases treated by new agents include pulmonary arterial hypertension, chronic obstructive pulmonary disease, diabetes, and obesity.PMID:38146706 | DOI:10.1093/ajhp/zxad337

Source: American Journal of Health-System Pharmacy : AJHP - December 26, 2023 Category: Drugs & Pharmacology Authors: Matthew H Rim Brittany L Karas Farah Barada Andrew M Levitsky Source Type: research